Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf/MEK/ERK signal cascade

Virology Journal

Volumn 4, Issue , 2007, Pages

  Marjuki, Henju ^a   Yen, Hui Ling ^a   Franks, John ^a   Webster, Robert G ^a,b   Pleschka, Stephan ^c   Hoffmann, Erich ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC RNA; HEMAGGLUTININ; MITOGEN ACTIVATED PROTEIN KINASE; PB1 PROTEIN; PROTEIN; RAF PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA; INFLUENZA VIRUS POLYMERASE BASIC PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PA PROTEIN, INFLUENZA VIRUSES; PB2 PROTEIN, INFLUENZA VIRUS; RIBONUCLEOPROTEIN; RNA DIRECTED RNA POLYMERASE; VIRUS PROTEIN;

ARTICLE; CELL MEMBRANE; CELL SURFACE; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; PLASMID; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE CULTURE; UPREGULATION; VIRAL GENETICS; VIRUS GENE; VIRUS REPLICATION; VIRUS TITRATION; ANIMAL; DOG; ENZYMOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY;

HUMAN INFLUENZA VIRUS; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

ANIMALS; DOGS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; RAF KINASES; RIBONUCLEOPROTEINS; RNA REPLICASE; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 38849122079     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-4-134     Document Type: Article

References (40)

1. Recent zoonoses caused by influenza A viruses. DJ Alexander IH Brown, Rev Sci Tech 2000 19 197 225 11189716
2. Epitopes on protein antigens: misconceptions and realities. WG Laver GM Air RG Webster SJ Smith-Gill, Cell 1990 61 553 556 10.1016/0092-8674(90)90464-P 1693095
3. Influenza - a model of an emerging virus disease. RG Webster SM Wright MR Castrucci WJ Bean Y Kawaoka, Intervirology 1993 35 16 25 8407243
4. Influenza revisited. JK Taubenberger DM Morens, Emerg Infect Dis 2006 12 1 2 16610160
5. 1918 Influenza: the mother of all pandemics. JK Taubenberger DM Morens, Emerg Infect Dis 2006 12 15 22 16494711
6. Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients. M Kaji A Watanabe H Aizawa, Respirology 2003 8 231 233 10.1046/j.1440-1843.2003.00457.x 12753540
7. Expression and replication of the influenza virus genome. RMA-K Krug V F I Julkunen MG Katze, New York, NY: Plenum Press 1989 89 152
8. The influenza viruses. RA Lamb, New York, NY: Plenum Press 1989 1 87 10303302
9. Lipid rafts and signal transduction. K Simons D Toomre, Nat Rev Mol Cell Biol 2000 1 31 39 10.1038/35036052 11413487
10. A novel influenza A virus mitochondrial protein that induces cell death. W Chen PA Calvo D Malide J Gibbs U Schubert I Bacik S Basta R O'Neill J Schickli P Palese, Nat Med 2001 7 1306 1312 10.1038/nm1201-1306 11726970
11. MAP kinases. Z Chen TB Gibson F Robinson L Silvestro G Pearson B Xu A Wright C Vanderbilt MH Cobb, Chem Rev 2001 101 2449 2476 10.1021/cr000241p 11749383
12. The Raf/MEK/ERK pathway: new concepts of activation. C Peyssonnaux A Eychene, Biol Cell 2001 93 53 62 10.1016/S0248-4900(01)01125-X 11730323
13. Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt. O Zugasti W Rul P Roux C Peyssonnaux A Eychene TF Franke P Fort U Hibner, Mol Cell Biol 2001 21 6706 6717 11533257 10.1128/MCB.21.19.6706-6717.2001
14. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. G Pearson F Robinson T Beers Gibson BE Xu M Karandikar K Berman MH Cobb, Endocr Rev 2001 22 153 183 10.1210/er.22.2.153 11294822
15. MEK inhibitors: the chemistry and biological activity of U its analogs, and cyclization products. JV Duncia JB Santella 3rd CA Higley WJ Pitts J Wityak WE Frietze FW Rankin JH Sun RA Earl AC Tabaka, Bioorg Med Chem Lett 0126 8 2839 2844 10.1016/S0960-894X(98)00522-8
16. Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3. C Ehrhardt C Kardinal WJ Wurzer T Wolff C von Eichel-Streiber S Pleschka O Planz S Ludwig, FEBS Lett 2004 567 230 238 10.1016/j.febslet.2004.04.069 15178328
17. MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells. O Planz S Pleschka S Ludwig, J Virol 2001 75 4871 4877 11312358 10.1128/JVI.75.10.4871-4877.2001
18. Exploitation of cellular signaling by HIV-1: unwelcome guests with master keys that signal their entry. W Popik PM Pitha, Virology 2000 276 1 6 10.1006/viro.2000.0581 11021988
19. Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. S Ludwig S Pleschka O Planz T Wolff, Cell Microbiol 2006 8 375 386 10.1111/j.1462-5822.2005.00678.x 16469051
20. MEK inhibition impairs influenza B virus propagation without emergence of resistant variants. S Ludwig T Wolff C Ehrhardt WJ Wurzer J Reinhardt O Planz S Pleschka, FEBS Lett 2004 561 37 43 10.1016/S0014-5793(04)00108-5 15013748
21. Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice. V Olschlager S Pleschka T Fischer HJ Rziha W Wurzer L Stitz UR Rapp S Ludwig O Planz, Oncogene 2004 23 6639 6646 10.1038/sj.onc.1207883 15235583
22. NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. WJ Wurzer C Ehrhardt S Pleschka F Berberich-Siebelt T Wolff H Walczak O Planz S Ludwig, J Biol Chem 2004 279 30931 30937 10.1074/jbc.M403258200 15143063
23. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. S Pleschka T Wolff C Ehrhardt G Hobom O Planz UR Rapp S Ludwig, Nat Cell Biol 2001 3 301 305 10.1038/35060098 11231581
24. Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling. H Marjuki MI Alam C Ehrhardt R Wagner O Planz HD Klenk S Ludwig S Pleschka, J Biol Chem 2006 281 16707 16715 10.1074/jbc.M510233200 16608852
25. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. G Gabriel B Dauber T Wolff O Planz HD Klenk J Stech, Proc Natl Acad Sci USA 2005 102 18590 18595 16339318 10.1073/pnas.0507415102
26. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. M Hatta P Gao P Halfmann Y Kawaoka, Science 2001 293 1840 1842 10.1126/science.1062882 11546875
27. The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. R Salomon J Franks EA Govorkova NA Ilyushina HL Yen DJ Hulse-Post J Humberd M Trichet JE Rehg RJ Webby, J Exp Med 2006 203 689 697 10.1084/jem.20051938 16533883
28. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. EK Subbarao W London BR Murphy, J Virol 1993 67 1761 1764 8445709
29. Mutational analysis of the conserved motifs of influenza A virus polymerase basic protein 1. SK Biswas DP Nayak, J Virol 1994 68 1819 1826 8107244
30. "Ambisense" approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template. E Hoffmann G Neumann G Hobom RG Webster Y Kawaoka, Virology 2000 267 310 317 10.1006/viro.1999.0140 10662626
31. Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. Z Li H Chen P Jiao G Deng G Tian Y Li E Hoffmann RG Webster Y Matsuoka K Yu, J Virol 2005 79 12058 12064 16140781 10.1128/JVI.79.18.12058-12064.2005
32. Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding. P Fechter L Mingay J Sharps A Chambers E Fodor GG Brownlee, J Biol Chem 2003 278 20381 20388 10.1074/jbc.M300130200 12646557
33. The active sites of the influenza cap-dependent endonuclease are on different polymerase subunits. ML Li P Rao RM Krug, Embo J 2001 20 2078 2086 11296240 10.1093/emboj/20.8.2078
34. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs. E Fodor M Crow LJ Mingay T Deng J Sharps P Fechter GG Brownlee, J Virol 2002 76 8989 9001 12186883 10.1128/JVI.76.18.8989-9001.2002
35. Acylation-mediated membrane anchoring of avian influenza virus hemagglutinin is essential for fusion pore formation and virus infectivity. R Wagner A Herwig N Azzouz HD Klenk, J Virol 2005 79 6449 6458 15858028 10.1128/JVI.79.10.6449-6458.2005
36. Influenza A Virus PB1-F2 Gene. R Cano S Jarraud J Pardos C Campese C Pelaz, Emerging Infectious Diseases 2006 12 17176586
37. Influenza A virus PB1-F2 gene. R Zell A Krumbholz P Wutzler, Emerg Infect Dis 2006 12 1607 1608 author reply 1608-1609 17176587
38. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. D Zamarin MB Ortigoza P Palese, J Virol 2006 80 7976 7983 16873254 10.1128/JVI.00415-06
39. Universal primer set for the full-length amplification of all influenza A viruses. E Hoffmann J Stech Y Guan RG Webster DR Perez, Arch Virol 2001 146 2275 2289 10.1007/s007050170002 11811679
40. A simple method for estimating fifty percent endpoints. LJMH Reed, Am J Hyg 1938 27 493 497